Related Experiment Videos
[Paraneoplastic syndromes in internal medicine]
M Zuffa1, I Rusnák, J Kubancok
1Interné oddelenie, NsP, Lipt. Mikulás.
Vnitrni Lekarstvi
|March 1, 1990
Summary
Paraneoplastic syndromes, often the first sign of cancer, are complex and multifactorial. Early recognition of these syndromes improves diagnosis and management of malignomas.
Area of Science:
- Oncology
- Immunology
- Internal Medicine
Context:
- Paraneoplastic syndromes complicate cancer diagnosis and treatment.
- Understanding these syndromes is crucial for early detection of malignomas.
- Their multifactorial origin involves biochemical, metabolic, and immunological factors.
Purpose:
- To investigate the incidence and clinical significance of paraneoplastic syndromes in patients with internal medicine-related malignant tumors.
- To highlight the role of paraneoplastic syndromes as early indicators of cancer.
- To explore the association between specific tumor types and paraneoplastic syndrome presentation.
Summary:
- A study of 1538 patients found paraneoplastic syndromes in 18.3%, with 9.4% presenting as the first symptom of malignancy.
- Thrombohemorrhagic and rheumatological syndromes were most frequent.
- Malignomas affecting the immune system showed the highest incidence of early paraneoplastic manifestations.
Impact:
- Improved early diagnosis of cancers through recognition of paraneoplastic syndromes.
- Potential for earlier intervention in treatable tumors.
- Recommendation for the classification of suspect paraneoplastic syndromes as precancerous conditions.